Volak LP et al., 2013-02: Randomised placebo-controlled six-way crossover study in eight healthy volunteers: 4 g curcuminoids with 24 mg piperine did not change the pharmacokinetics of midazolam (CYP3A), flurbiprofen (CYP2C9) or paracetamol (UGT/SULT).
the curcuminoid/piperine treatment produced no meaningful changes in plasma C(max), AUC, clearance, elimination half-life or metabolite levels of midazolam, flurbiprofen or paracetamol
Abstract, Results
Volak LP et al., 2013-02: Randomised placebo-controlled six-way crossover study in eight healthy volunteers: 4 g curcuminoids with 24 mg piperine did not change the pharmacokinetics of midazolam (CYP3A), flurbiprofen (CYP2C9) or paracetamol (UGT/SULT). Tests the CYP3A4 inhibition claim the book's caution rests on, at a high oral dose, and finds no clinically meaningful interaction; unconjugated curcumin was below assay threshold. Comparator: placebo pre-treatment. Funder and disclosures not carried in the PubMed record. Study type: randomized trial.
